7 Penny Stocks Flashing Buy Signals Right Now - And 10 You Must Avoid (April 2026)
Our multi-indicator screener crunched 85+ tickers to surface the strongest momentum setups and the most dangerous downtrends in the small-cap universe this week.
by James
Published Apr 01, 2026 | Updated Apr 01, 2026 | 📖 7 min read
Article continues below advertisement
Small-cap and penny stocks can deliver explosive returns -but they can also evaporate your capital overnight. That's why we run every ticker through a 15-indicator technical screener covering momentum (RSI, MACD, Stochastic), trend strength (ADX, DI crossovers, Aroon), volume confirmation (OBV, MFI), and risk structure (Bollinger Bands, ATR, historical volatility).
Each stock receives a composite score from -15 to +15, a rank, and a clear action signal. Here's what this week's scan revealed.
The Top 7: Strongest Technical Setups
These are the stocks where multiple indicators are aligning in a bullish formation. Volume is confirming price action, directional momentum is positive, and -in the best cases -a golden cross has formed on the moving averages.
1. GEVO -$2.73 | Score: +15 | Rank #1
Signal: STRONG BUY · Entry Type: Trend Continuation · Cross: Golden
Gevo leads the screener with the highest composite score of +15, driven by a rare confluence of bullish signals. The stock has printed a golden cross (SMA50 at $2.08 crossing above SMA200 at $1.93), Aroon Up is pegged at 100, and OBV is rising alongside a bullish MACD histogram. The stock is sitting just 1.8% off its recent high -practically at breakout level.
| Indicator | Value |
|---|---|
| RSI | 71.9 (Overbought) |
| MACD | Bullish |
| ADX | 42.0 (Strong Trend) |
| OBV | Rising |
| 1M Return | +43.7% |
| Entry Zone | $1.91 – $2.34 |
| Targets | $3.06 → $3.22 → $3.76 |
| Stop Loss | $2.48 |
RSI at 72 -approaching overbought. The screener recommends tightening your stop to breakeven if already in the trade.
2. ASTC -$5.15 | Score: +13 | Rank #2
Signal: STRONG BUY · Entry Type: Trend Continuation · Volatility: 348%
Astrotech has been the standout mover -up an astounding 123% in a single week and 88% over the past month. The ADX at 45.8 confirms a strong trend is in play, DI spread is overwhelmingly bullish (+54.7 vs -9.1), and volume is rising in lockstep. The MFI reading of 99.9 is essentially maxed out.
| Indicator | Value |
|---|---|
| RSI | 85.5 (Overbought) |
| ADX | 45.8 (Strong Trend) |
| MFI | 99.9 (Overbought) |
| OBV | Rising |
| 1W Return | +123% |
| 1M Return | +88% |
Extended -do NOT chase. RSI 85 + MFI 99.9 = severely overbought. Wait for a pullback to the $4.50–$3.60 zone before considering entry.
3. KVHI -$8.96 | Score: +12 | Rank #3
Signal: STRONG BUY · Entry Type: Trend Continuation · Cross: Golden
KVH Industries is trending cleanly with a golden cross, strong ADX (45.2), and a bullish DI spread. Unlike ASTC, it hasn't gone parabolic -it's only 2.5% off its high, suggesting a steady uptrend rather than a blow-off spike. OBV is rising, confirming institutional accumulation, and the stock is trading well above both its 50-day ($6.92) and 200-day ($6.14) moving averages.
| Indicator | Value |
|---|---|
| RSI | 68.6 |
| ADX | 45.2 (Strong Trend) |
| 3M Return | +32.9% |
| Entry Zone | $5.45 – $7.70 |
| Targets | $10.06 → $10.61 → $11.46 |
| Stop Loss | $8.13 |
This is one of the cleaner setups on the board -steady trend, volume confirmation, no extreme overbought readings. Consider tightening stop to breakeven as it approaches $10.
4. OPAL -$2.52 | Score: +11 | Rank #4
Signal: STRONG BUY · Entry Type: Breakout · OBV: Rising
OPAL Fuels is building momentum with a bullish MACD, rising OBV, and a strong +DI/−DI spread (32.5 vs 15.4). The stock has returned 14% in the past week and 17% over the past month. It trades above both key moving averages and is showing breakout characteristics near its entry zone ceiling.
| Indicator | Value |
|---|---|
| RSI | 60.0 |
| Entry Zone | $1.88 – $2.23 |
| Targets | $2.87 → $3.04 → $3.28 |
| Stop Loss | $2.26 |
5. QUIK -$9.43 | Score: +10 | Rank #5
Signal: STRONG BUY · Entry Type: Breakout · Cross: Golden
QuickFee holds a golden cross and bullish DI signal, with a 3-month return of +53.6%. The MACD histogram has turned slightly negative, which keeps this in "Monitor" territory rather than full conviction. Wait for the MACD to recross bullish before adding new positions.
| Indicator | Value |
|---|---|
| Cross | Golden |
| 3M Return | +53.6% |
| Entry Zone | $8.50 – $9.19 |
| Targets | $10.70 → $11.34 |
| Stop Loss | $8.47 |
6. FDMT -$9.30 | Score: +9 | Rank #6
Signal: STRONG BUY · Entry: STRONG ENTRY · Cross: Golden
4D Molecular Therapeutics flashed a Strong Entry signal -one of only three stocks on the entire board to earn that designation. Five out of six entry conditions are met: golden cross, bullish MACD, rising OBV, bullish DI signal, and a breakout pattern forming. The one knock is a modest R:R of 1.3:1, so position sizing discipline is critical.
| Indicator | Value |
|---|---|
| Conditions Met | 5/6 |
| Entry Zone | $7.91 – $8.89 |
| Targets | $10.79 → $11.53 → $12.27 |
| Stop Loss | $8.18 |
7. SIDU -$2.32 | Score: +9 | Rank #6 (tied)
Signal: STRONG BUY · Entry: STRONG ENTRY · Cross: Golden
Sidus Space earned a Strong Entry signal with 5 of 6 conditions met. The golden cross is in place, OBV is rising, and the bullish DI spread is supportive. The concern is the R:R ratio of only 0.3:1 -meaning the current risk/reward from this price level isn't favourable. Best approach: set alerts at the $1.74–$2.24 entry zone and buy on a pullback.
| Indicator | Value |
|---|---|
| Cross | Golden |
| R:R Ratio | 0.3:1 (Poor) |
| Entry Zone | $1.74 – $2.24 |
| Targets | $3.27 → $4.94 |
| Stop Loss | $1.85 |
Strong setup but poor risk/reward at current price. Patience here could mean a much better entry.
Key Patterns This Week
- Golden crosses dominate the leaders. Five of the top seven stocks (GEVO, KVHI, QUIK, FDMT, SIDU) have their 50-day SMA trading above the 200-day -the classic long-term bullish signal.
- Volume matters. Every high-conviction pick has either rising OBV or strong MFI readings. Price without volume is noise.
- R:R ratios are thin. Even the best setups are showing 1.3:1 reward-to-risk -meaning position sizing and stop discipline are non-negotiable this week.
- The avoid list is massive. Over half of the screened universe (40+ stocks) is in confirmed downtrend territory. This is not a broad-market rally -it's selective momentum.
The Danger Zone: 10 Stocks to Avoid
These tickers scored -10 or worse on our composite ranking -meaning nearly every technical indicator is flashing bearish. Confirmed downtrends with high ADX readings, death crosses, falling OBV, and oversold indicators that keep getting more oversold. Do not try to "catch the knife" here.
| Ticker | Price | Score | ADX | % Off High | 1M Return | Signal |
|---|---|---|---|---|---|---|
| IOBT | $0.06 | -15 | 40.3 | -97.5% | -81.8% | EXIT NOW |
| SGMO | $0.25 | -14 | 14.2 | -66.2% | -41.9% | AVOID |
| ORGN | $2.28 | -14 | 37.9 | -91.7% | -48.5% | EXIT NOW |
| KITT | $0.50 | -12 | 15.7 | -95.2% | -35.1% | AVOID |
| QSI | $0.78 | -12 | 32.2 | -70.3% | -16.1% | EXIT NOW |
| UAVS | $0.90 | -11 | 11.3 | -69.8% | -14.3% | AVOID |
| RKDA | $1.38 | -11 | 31.9 | -74.8% | -29.6% | EXIT NOW |
| ARBE | $0.61 | -11 | 26.7 | -77.3% | -23.8% | EXIT NOW |
| CBAT | $0.83 | -11 | 36.5 | -32.5% | -19.4% | EXIT NOW |
| VLN | $1.13 | -11 | 25.3 | -63.8% | -23.7% | EXIT NOW |
The common thread across the avoid list: death crosses, falling OBV, bearish DI spreads, and stocks trading 60–97% below their highs. These aren't "cheap" -they're in structural decline. The screener's EXIT NOW signal fires when the score drops below -8 and the ADX confirms a strong directional trend -which in these cases, is straight down.
Watchlist: Not Ready Yet, But Worth Tracking
STXS -$1.84 | Momentum Build
Five out of six entry conditions met on a momentum setup, but the R:R is only 0.4:1. The MACD just turned bullish and OBV is rising -if price can reclaim the $2.11 level (its SMA50), this could upgrade to a full entry. Worth setting an alert.
EDIT -$2.47 | Breakout Watch
Editas Medicine popped 10.8% today with rising OBV and a bullish DI spread. It's still carrying a death cross, but the stock has gained nearly 10% on the week and 15% on the month. A move above $2.58 (SMA200) could trigger a trend reversal signal.
ARCT -$7.72 | Overbought Alert
Arcturus Therapeutics jumped 11.9% with rising OBV -but the Stochastic %K has hit 95.8 (severely overbought). This is a textbook "wait for a pullback" scenario. The entry zone of $6.22–$7.00 would offer a much better risk/reward setup.
How to Use This Screener
Our composite scoring system aggregates 15 technical indicators into a single actionable score. Here's how to interpret the output:
- Score +10 to +15: Multiple bullish indicators aligned. Look for volume confirmation before entering. These are your highest-conviction setups.
- Score +5 to +9: Positive momentum building, but not all conditions met. Good for watchlists and smaller position sizes.
- Score 0 to +4: Mixed signals. The stock may be transitioning. Wait for clarity before committing capital.
- Score -1 to -7: Bearish indicators outnumber bullish ones. Avoid new long positions. If you're already in, consider tightening stops.
- Score -8 and below: Confirmed downtrend. If the ADX is above 25, the trend has conviction. EXIT NOW signals mean the technical damage is severe -don't wait for a bounce that may never come.
Disclaimer: This article is for educational and informational purposes only and does not constitute financial advice. The technical analysis and screener signals presented are based on historical price data and technical indicators, which are inherently backward-looking and do not guarantee future results. Penny stocks and small-cap equities carry significant risk, including the potential for total loss of investment. Always conduct your own due diligence and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.
Related Articles
Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.